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Many strains of Brettanomyces pose a major threat to the commercial brewing industry by 
producing phenolic off-flavors, while a few strains contribute desirable characteristics in unique 
beer styles. This genus of yeast possesses a two-step pathway that converts hydroxycinnamic 
acids (HCAs) to vinyl and ethyl derivatives that add unwanted flavors and aromas to the final 
beverage. This project focused on analyzing Brettanomyces yeast isolates for variation in 
phenolic acid decarboxylase activity (PAD), which catalyzes the first step in the pathway. Each 
strain was grown in the three different common HCAs (ferulic acid, p-coumaric acid, caffeic 
acid) to understand each strain’s reactivity to the compound. Strains displayed variation in their 
PAD activity and growth in HCAs. Most good brewing strains were highly sensative to p-
coumaric acid, and displayed significant lags in their growth in p-coumaric and ferulic acid. All 
strains were highly resistant to caffeic acid. These data show some trends towards differences in 
good brewing strains and may lead to easier identification methods for yeast strains that may be 
good for brewing. 
 
 
Molecular and biochemical analysis of phenolic acid decarboxylase from 
Brettanomyces yeast isolates 
Introduction 
Beer ales have been produced and served longer than any other beverage currently 
produced. Historical records indicate that ales date back to the 5th millennium BC through its 
depiction in the ancient writings of Egypt and Mesopotamia. The oldest record of an ale 
beverage dates back 7,000 years to the Iranian region, revealed through chemical analysis of 
ancient pottery discovered (Mirsky, 2007).  It is possible that this beverage was discovered 
accidently, in which cereal-containing fluid was spontaneous inoculated with microflora and a 
flavorful fermented beverage was discovered. Ironically, these techniques using spontaneous 
fermentation are undergoing a resurgence. The dawn of a new kind of beverage emerged, and 
most cultures around the world are independently discovering this phenomenon.  
 Ales were produced on a domestic scale even before the industrial revolution. More 
sophisticated brewing techniques evolved around the 19th century with the invention of 
thermometers and hydrometers, and more importantly the discovery of yeast. Today, brewing is 
a ~300 billion dollar a year industry (Research and Markets).  
 Historically, different regions all produced different types of beers varying in their 
organoleptic properties. These properties are specific to the flavor and aroma of the beverage. 
The properties vary due to the specific cereal used, but contrary to popular belief, are immensely 
reliant on the genus, species, and strain of the yeast and bacteria used in the inoculation. The 
domestication of some of these strains, specifically Saccharomyces cerevisiae revolutionized 
commercial fermentation, allowing fermenters of beer and wine to control their process and 
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produce a more predictable consistent product. There are now hundreds of different strains of 
yeast available to brewers all used to produce different types of beers, each contributing a unique 
physiological mechanism to produce variable organoleptic properties. Common protocol requires 
commercial breweries to inoculate wort with pure strains of yeast as it cools. This ensures 
production of desired aromas and flavors in the final product (Erten, 2007; Suihko, 1993).  
Though commercial fermentation has brought much success to the brewing industry, 
certain biological complications pose a major threat. Brettanomyces yeast have a large impact on 
the brewing process, and often result in spoilage, leading to significant economic loss 
(Fugelsang, 1997). Control of this species is a top priority for brewers and winemakers 
worldwide. The American Vineyard Foundation ranked influence of yeast on chemistry and 
flavor as a top priority in enology related areas. Brettanomyces are ubiquitous in nature and 
display long-term survival on brewery and winery surfaces such as walls, grape processing 
equipment, and aging barrels (Woolfit, 2007). There are presently five species recognized within 
the genus Brettanomyces: B. bruxellensis, B. anomalus, B. nanus, B. naardenensis, and B. 
custersianus. Teleomorph (spore-forming) forms have been reported for B. bruxellensis and B. 
anomalus and are identified as the Dekkera genus; these forms are rare and Brettanomyces will 
be used in this manuscript. Brettanomyces contribute to spoilage via a two-step pathway, initially 
involving metabolism of plant derived compounds known as hydroxycinnamic acids (HCAs). 
HCAs are a ubiquitous plant compound that aid in anti-microbial properties, and are thus present 
in wine must and beer wort (Faulds, 1999). In this two step pathway, Brettanomyces convert 
HCAs to volatile phenolic compounds that contribute off-flavors and aromas to fermented 




 Though this genus of yeast has been damaging to the commercial fermentation industry, 
it has also brought much opportunity, especially to the craft beer industry. Craft brewing is 
characterized by production of unique small batches of beer. Brettanomyces offers a unique 
quality to fermentation that conventional strains cannot. Though many strains of this yeast 
contaminate the product, certain strains also offer unique favorable organoleptic properties. By-
products of some of these strains have been described as smokey, clove-like, and fruit-like. Craft 
brewing companies have taken advantage of these unique properties to produce contemporary 
products. The aforementioned spontaneous fermentation method of brewing also takes advantage 
of unique species of yeast. In this method, beer wort is left open to the environment to be 
inoculated by the local environmental flora. In this scenario, uncharacterized strains of yeast and 
bacteria to metabolize offer distinctly different flavors and aromas to the beverage. Every strain 
offers something different and unique to the product, and it is largely attributed to the PAD 
enzyme pathway, but why is that species of yeast using the same biochemical pathway in 
metabolism produce by-products with notably different organoleptic properties? 
 Phenolic acid decarboxylase (PAD) is the first enzyme involved in the two-step pathway 
converting HCAs to vinyl derivatives that are major contributors to phenolic off-flavor in beer 
and wine, however this enzyme is also responsible for producing organoleptic properties that are 
considered favorable in some fermentations. Some strains also encode vinyl reductase enzyme 
that convers the vinyl compounds into ethyl derivatives, also contributing to varying 






Figure 1  Two-step pathway for metabolism of HCAs in yeast (van Beek, 2000). 
 This study aims to understand why varying strains with similar biochemistry display vastly 
differentiated organoleptic properties in fermentation, and to establish trends correlating certain 
enzymatic behavior to species and or good brewing potential. To accomplish this, we aimed to 
determine the level of variation of PAD enzyme activity towards three common HCAs among a 
panel of 12 isolates of local environmental Brettanomyces isolates and commercially available 










Table 1  Strain identification of each species studied 
Strain Number Species Source Brewing Potential 
1 Brettanomyces 
bruxellensis 

























































These data will aid in identifying a correlation between substrate specificity and spoilage 
potential. Strains were also analyzed for the presence of each enzyme in the pathway. It was 
hypothesized that good brewing strains would display higher PAD enzyme activity, and there 




Materials and Methods 
HCA Metabolism 
200µL samples of growth medium (MYPG) supplemented with 2 mM HCA (ferulic acid, p-
coumaric acid, caffeic acid) and were arranged in 96-well microtiter plates. Each well was 
inoculated with 103 cells of each strain. Each experiment was conducted in triplicate for 
statistical analysis. Plates were incubated at 28°C in a moist environment for 10-14 days, as 
appropriate. Control (HCA in sterile culture medium) was subjected to an absorbance scan at 
200-400nm wavelengths. Peaks are typically 313nm for ferulic acid and caffeic acid, and 287nm 
for p-coumaric acid, however the peak was determined empirically for each experiment. Yeast 
cells were removed from each sample via centrifugation and supernatant analyzed for absorbance 
at the peak wavelength. “Percent of original absorbance remaining” was used as a target value 
since spectral scan curves show low but measurable absorbance at the substrate peak level, even 





Figure 2  Sample spectral scan of ferulic acid control and yeast supernatant to determine percent 
of ferulic acid remaining. SMP02, 4-vinyl guaiacol control; SMP03, strain 6; SMP04, strain 7; 
SMP05, ferulic acid control. 
HCA Minimum Inhibitory Concentration 
200µL samples of MYPG supplemented with 0-20 mM HCA (ferulic acid, p-coumaric acid, 
caffeic acid) and were arranged in 96-well microtiter plates. Each well was inoculated with 103 
cells of each strain. Each experiment was conducted in triplicate for statistical analysis. Plates 
were incubated at 28°C in a moist environment for 48-72 hours. Results were interpreted 
qualitatively by the observation of growth at each concentration. 
Growth in HCA 
Strains were grown in 20 mL of MYPG supplemented with 4 mM HCA (ferulic acid, p-coumaric 




tube was inoculated with 105 cells of each strain. Vials were agitated and incubated at 24°C for 
14 days. Absorbance of culture was determined for each sample at 600 nm at regular time points. 
Results 
Twelve Brettanomyces isolates were grown in 2mM HCA. After ten days incubation, 
HCA remaining was determined by comparing the absorbance of the sample to starting medium 
at either 287nm (p-coumaric acid) or 313nm ferulic acid and caffeic acid) (Figure 2). 
Preliminary analysis of PAD activity in the local isolates of Brettanomyces yeast as well 
as several commercially available brewing strains demonstrated significant variation, particularly 
towards ferulic acid and p-coumaric acid. All strains displayed significantly less PAD activity 
towards caffeic acid while some strains were unable to metabolize the compound at all (Figure 
3). 
As can be seen in figure 3, there is wide variation among isolates for metabolism of the 
different substrates. Some common themes were also observed. All 12 strains utilized caffeic 
acid least efficiently of the three HCAs tested, ranging from not using this substrate at all, to 
reducing the peak absorbance by about 50 percent. Ferulic acid and p-coumaric acid were 
metabolized equally efficiently by five of the strains, however the proportion remaining after 
metabolism ranged from 20 percent to 50 percent within this group. Six strains metabolized 
ferulic acid more efficiently than p-coumaric acid, again with wide strain-to-strain variation. 





Figure 3  Fraction of hydroxycinnamic acid remaining after 10 days of incubation with each 
Brettanomyces strain. 
 
The minimum inhibitory concentration (MIC) of each HCA to each strain was 
determined by incubating each strain in MYPG supplemented with 0-20 mM HCA and 
observing growth after 2-3 days.  
All strains grew well in media supplemented with caffeic acid at 20mM, exhibiting no 
inhibition by this compound. Strains 1, 2, and 7-11 also grew at 20mM p-coumaric acid. These 
strains represent both B. bruxellensis and B. anomalus, and brewing and non-brewing strains of 
each species. Strains 3, 4, 5, 6, and 12 were unable to grow in p-coumaric acid concentrations of 




























are B. anomalus. Ferulic acid provided the strongest inhibition, with one strain (#4) growing in 
14mM, but no others growing at concentrations above 12mM. Strain 4 is an environmental 
isolate used successfully in brewing. Inhibition of growth above 6mM was observed for three of 
the strains (3, 5, and 12). Growth at 12mM but not above this concentration was seen for strains 
6, 7, 9, 10, and 11, all strains that have been used successfully in brewing. The remaining strains 
were inhibited by intermediate concentrations of ferulic acid (Table 2). 
 Table 2  Minimum inhibitory concentration of each yeast strain for each HCA* (in mM). 
 1 2 3 4 5 6 7 8 9 10 11 12 
FA 10 10 8 14 8 12 12 16 12 12 12 8 
pCA 20 20 10 12 8 14 20 20 20 20 20 8 
CA 20 20 20 20 20 20 20 20 20 20 20 20 
* FA.: Ferulic acid; pCA: p-Coumaric acid; CA: Caffeic acid 
Each strain was grown in 4 mM HCA for 14 days. Absorbance readings of cultures were 
read at regular intervals to generate grown curves (Figure 4). Most strains displayed variation in 
their growth patterns, however it was noted that some strains display a significant growth lag 
between ferulic acid and p-coumaric acid. This trend was particularly evident in strains with 

































































































































































































Figure 4  Growth curves of all strains grown in 5 mM HCA and ethanol as a control for 14 days 
with absorbance readings taken as appropriate. Y-axis: Absorbance; X-axis: hours. A.) Strain 1; 
B.) Strain 2; C.) Strain 3; D.) Strain 4; E.) Strain 5; F.) Strain 6; G.) Strain 7; H.) Strain 8; I.) 
Strain 9; J.) Strain 10; K.) Strain 11; L.) Strain 12. 
Discussion 
A variety of yeast strains can be naturally found on fruits skins, grains, and a range of 
other environments. In this study, 8 strains were isolated and characterized from several different 
fruits. Isolates were identified based on RFLP mapping of the 5.8S rDNA region to be either B. 
bruxellensis or B. anomalus, but all displayed a variety of different physiological characteristics. 
Some strains displayed properties appropriate for fermentation while others were deficient in 
alcohol tolerance (Lentz, 2014). It is well recognized that although yeast are abundant in nearly 
every environment, only a small amount are likely to possess the physiological characteristics for 
potential use in commercial brewing. Even fewer of these strains will possess favorable 
organoleptic properties.  
Total contribution of yeast to beverage characteristic is very complex, but a simple 
biochemical pathway underlies some of a strains contribution to the flavor and aroma of 
alcoholic beverages. All plant cells contain members of a family of compounds, the HCAs. They 
perform a structural role in the plant cell wall and also possess antimicrobial properties. Some 
yeast and bacteria that live on plant matter have developed pathways to metabolize and detoxify 
HCAs. In Brettanomyces and other microbes, a two-step pathway is used to metabolize these 
compounds. The vinyl and ethyl compounds produced depend on the specific HCAs present in 
the starting plant material. Barley is rich in ferulic acid, which is known to be metabolized to 
compounds described as spicy, clove-like, smokey, While p-coumaric acid yields compounds 




varying concentrations of ferulic acid, p-coumaric acid, and caffeic acid to ascertain trends 
towards identifying differences in yeast species and good brewing strains versus poor brewing 
strains. These data uncover several trends towards identifying differences in good brewing 
strains and not good brewing strains. 12 strains were analyzed, seven of which were 
characterized as not good for brewing. Good brewing strains displayed trends towards having 
significant differences between p-coumaric and ferulic acid minimum inhibitory concentration. 
Growth curves demonstrated that good brewing strains also showed a trend towards a significant 
lag early in growth when exposed to p-coumaric and ferulic acid. It was also noted that all strains 
were highly resistant to caffeic acid, and good brewing strains were highly tolerant to p-coumaric 
acid. 
Using UV spectral analysis of HCA containing media before and after exposure to 
Brettanomyces, it is possible to observe the PAD enzyme activity of these organisms by 
measuring how much of the compound remains. Analysis of each strain using each HCA 
displayed variation in PAD activity in all strains, however there were some trends noted. In this 
analysis, a trend was noted in good brewing strains, in which most displayed significant 
differences between the PAD activity towards ferulic acid and p-coumaric acid, with less ferulic 
acid remaining in the final media (Figure 3). This suggests that the PAD enzyme is much more 
reactive towards ferulic acid. Ferulic acid is the most abundant HCA in varieties of barley, but all 
HCAs are present in all plant cells. Ferulic acid exists in barley at a factor of 10 more than p-
coumaric acid and a factor of 20 times more than caffeic acid, thus it can be suggested that these 
organisms have evolved an increased ability to  metabolize ferulic acid due to its high 




acid is in the greatest concentration in the HCA content of plant tissue, these data suggest that 
these species are more tolerant to ferulic acid and their associated PAD enzyme is much more 
efficient at breaking it down, making them better candidates for brewing.  
There was an early lag in growth curves of good brewing strains noted between ferulic 
acid and p-coumaric acid, and ferulic acid had the most inhibiting effect (Figure 4). These data 
support Harris (2007) findings that HCAs showed reduced growth and 1mM ferulic acid 
completely inhibited the growth of some species. Ferulic acid appears to be the most toxic 
compound to these organisms, while their PAD enzyme seems to break down the compound 
more efficiently.  
All strains displayed significant reduced reactivity toward caffeic acid (Table 2). Growth 
curves with this added compound showed no statistically significant difference between caffeic 
acid and the control (Figure 4). Caffeic acid appears to be the least toxic compound to these 
organisms. Caffeic acid is present in barley in the least abundance, which may be due to their 
decreased effectiveness as an anti-microbial compound (Yu, 2001).  
 Data also demonstrated that good brewing strains were highly tolerant to p-
coumaric acid. This HCA is present in the second most abundance in barley. Thus once again, 
this may allude to these organisms having a more evolved PAD enzyme that is more efficient at 
breaking down HCAs, especially those in the highest abundance in barley.  
There appears to be one major trend noted in this study: good brewing strains display an 
increased ability to break down HCAs, p-coumaric acid and ferulic acid in particular. These data 




results in an increased fermentation profile. HCAs may have a more inhibitory effect on not-
good brewing strains resulting in fermentation reduction and abnormal phenolic characteristics. 
It is also possible that the inhibitory effect may alter the enzymatic breakdown of HCAs resulting 
in off-flavors. Thus our hypothesis was supported, good brewing strains demonstrate an increase 
in PAD enzyme activity; however, there were no distinct difference between B. anomalous and 
B. bruxellensis. These differences have the potential to facilitate the discovery of new strains of 
yeast with an appropriate fermentation profile. 
  Future experiments will focus on determining if HCA inhibition is correlated to phenolic 
off-flavor or bad brewing potential. We have also began cloning the gene to characterize the 
PAD enzyme. Once an enzyme assay is developed, pH and temperature optima will be 
determined under a variety of conditions. Protein extracts will be mixed with different HCA 
substrates and monitored by UV spectroscopy. Kinetic parmeters such as Km and Vmax will also 
be determined. Targeted mutations in cloned gene will ultimately be used to understand 
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